Wedbush Boosts Vera Therapeutics (NASDAQ:VERA) Price Target to $21.00
Vera Therapeutics (NASDAQ:VERA – Free Report) had its target price boosted by Wedbush from $16.00 to $21.00 in a report published on Friday morning, Benzinga reports. They currently have a neutral rating on the stock. VERA has been the subject of several other research reports. JPMorgan Chase & Co. dropped their price objective on shares […]
More Stories
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Sees Large Decrease in Short Interest
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) was the target of a significant decrease in short interest in the...
Valmet Oyj (OTCMKTS:VOYJF) Sees Large Decrease in Short Interest
Valmet Oyj (OTCMKTS:VOYJF – Get Free Report) was the recipient of a significant drop in short interest during the month...
Ubisoft Entertainment SA (OTCMKTS:UBSFY) Sees Significant Decrease in Short Interest
Ubisoft Entertainment SA (OTCMKTS:UBSFY – Get Free Report) was the target of a large drop in short interest in the...
SecureWorks Corp. (NASDAQ:SCWX) Short Interest Down 33.4% in October
SecureWorks Corp. (NASDAQ:SCWX – Get Free Report) was the target of a significant drop in short interest in October. As...
SecureWorks Corp. (NASDAQ:SCWX) Short Interest Down 33.4% in October
SecureWorks Corp. (NASDAQ:SCWX – Get Free Report) was the target of a significant drop in short interest in October. As...
SLM Co. (NASDAQ:SLMBP) Short Interest Update
SLM Co. (NASDAQ:SLMBP – Get Free Report) was the recipient of a large drop in short interest in October. As...